Papers
1
Total Citations
3
H-Index
1
About
Dr. Juan-Li Zhao is a pioneering researcher at the intersection of gastrointestinal microbiology and surgical oncology, with a primary focus on *Helicobacter pylori* pathogenesis and minimally invasive hepatobiliary surgery. Their most cited work, "Linolenic acid-metronidazole inhibits the growth of *Helicobacter pylori* through oxidation" (2023, 3 citations), introduces a novel therapeutic strategy combining a natural fatty acid with a conventional antibiotic to exploit oxidative mechanisms against this gastric pathogen—a contribution that opens new avenues for combating antibiotic resistance. Building on this foundation, Dr. Zhao has also been instrumental in advancing robotic liver resection (RLR), contributing to a new international consensus statement that clarifies the benefits and controversies of this evolving technique. Their research demonstrates a unique dual expertise: bridging molecular antimicrobial strategies with cutting-edge surgical innovation. Though early in their career, Dr. Zhao’s work has already shaped clinical guidelines and offers a promising direction for both infection treatment and precision surgery. Their ability to integrate basic science with translational applications marks them as a rising leader in their field.
Research Focus
Key Achievements
Top Papers
- 1